Bank of Montreal
NKTR icon

Bank of Montreal’s Nektar Therapeutics NKTR Stock Holding History

Bank of Montreal’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,233
Closed -$350K – 3859
2013
Q3 		$350K Buy
+2,233
New +$413K ﹤0.01% 1978

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal's NKTR Position: Q2 2026 in Review

Bank of Montreal opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 4,442 shares worth $310K. The stake represents ﹤0.01% of the portfolio and ranks #2749 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in NKTR as recently as Q4 2024.

Bank of Montreal first reported a position in NKTR in Q2 2014 and has held it in 42 quarters since. The position peaked at $14.4M in Q3 2018. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Bank of Montreal held 4,442 shares of Nektar Therapeutics worth $310K as of Q2 2026.
  • Nektar Therapeutics was a new Bank of Montreal position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2749 holding.
  • Bank of Montreal first reported a position in Nektar Therapeutics in Q2 2014 and has held it in 42 quarters since.
  • Bank of Montreal's Nektar Therapeutics position peaked at $14.4M in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.